Latest Breaking News On - Biocapital europe - Page 8 : comparemela.com

Celyad Oncology Announces March 2021 Conference Schedule Regulatory News: Celyad Oncology SA (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (Euronext Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company plans to participate at the following virtual investor conferences in March 2021: H.C. Wainwright Global Life Sciences Conference Date: Tuesday, March 9 Wednesday, March 10, 2021 Time: 7:00 a.m. ET 1:00 p.m. CET Webcast: A webcast of the presentation will be available in the Events section of the Celyad Oncology website for approximately 90 days from the start of the event

Mont saint guibertWaals gewestNew yorkUnited statesWalloon regionFrance generalSara zelkovicBiocapital europeExchange commissionCommunications investor relationsLifesci advisorsHc wainwright global life sciences conferenceRegulatory newsEuronext nasdaqGlobal life sciences conferenceCelyad oncology